Clinigen Group PLC

Clinigen Group PLC

Health CarePharmaceuticals & Biotechnology
  • Price (GBX)712.50
  • Today's Change-7.50 / -1.04%
  • Shares traded156.38k
  • 1 Year change-25.51%
  • Beta1.5430
Data delayed at least 20 minutes, as of Aug 06 2020 16:35 BST.
More ▼

Key statistics

On Thursday, Clinigen Group PLC (CLIN:LSE) closed at 712.50, -28.75% below its 52-week high of 1,000.00, set on Jan 24, 2020.
52-week range
350.40Mar 19 20201,000.00Jan 24 2020
Markit short selling activity
Previous close720.00
Average volume310.26k
Shares outstanding132.90m
Free float127.26m
P/E (TTM)69.39
Market cap956.87m GBP
EPS (TTM)0.1038
Annual div (ADY)6.90
Annual div yield (ADY)0.96%
Div ex-dateMar 19 2020
Div pay-dateApr 17 2020
Data delayed at least 20 minutes, as of Aug 06 2020 16:35 BST.
More ▼

Investors Chronicle View

The last IC recommendation on Clinigen Group PLC shares was Buy at 628.00 on 16 Apr 2020Read the full article
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.